Doxazosin in the treatment of benign prostatic hypertrophy: an update

References

• AkanHBasarMDalvaI1998The early effects of doxazosin on benign prostatic hyperplasiaArch Ital Urol Androl70414
   Google Scholar
• AndersenMDahlstrandCHoyeK2000Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasiaEur Urol38400911025377
   PubMed Web of Science ®Google Scholar
• [AUA] AUA Practice Guidelines Committee2003AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendationsJ Urol1705304712853821
   PubMed Web of Science ®Google Scholar
• BarryMJFowlerFJJrBinL1997A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancerJ Urol158488919224330
   PubMed Web of Science ®Google Scholar
• BarryMJWillifordWOChangY1995Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?J Urol154177047563343
   PubMed Web of Science ®Google Scholar
• [CC] The Cochrane Collaboration2001Review Manager (RevMan) [Computer program] Version 41 for WindowsOxfordEngland
   Google Scholar
• ChappleCRCarterPChristmasTJ1994A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstructionBr J Urol745067519112
   PubMedGoogle Scholar
• ChappleCR2001Lower urinary tract symptoms suggestive of benign prostatic obstruction –Triumph: design and implementationEur Urol39Suppl 331611275740
   PubMed Web of Science ®Google Scholar
• ChristensenMMBendix HolmeJRasmussenPC1993Doxazosin treatment in patients with prostatic obstruction. A double-blind placebo-controlled studyScand J Urol Nephrol2739447684157
   PubMed Web of Science ®Google Scholar
• ChuteCGPanserLAGirmanCJ1993The prevalence of prostatism: a population-based survey of urinary symptomsJ Urol1508597685427
   PubMed Web of Science ®Google Scholar
• de ReijkeTMKlarskovP2004Comparative efficacy of two α1-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargementBJU Int937576215049986
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdN1986Meta-analysis in clinical trialsControl Clin Trials7177883802833
   PubMed Web of Science ®Google Scholar
• DickersinKSchererRLefebvreC1994Identifying relevant studies for systematic reviewsBMJ3129447
   Google Scholar
• FawzyABraunKLewisGP1995Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter studyJ Urol15410597539853
   PubMed Web of Science ®Google Scholar
• FultonBWagstaffAJSorkinEM1995Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasiaDrugs492953207537194
   PubMed Web of Science ®Google Scholar
• GillenwaterJYConnRLChrysantSG1995Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter studyJ Urol154110157539854
   PubMed Web of Science ®Google Scholar
• JanknegtRAChappleCR1993Efficacy and safety of the alpha-1 blocker doxazosin in the treatment of benign prostatic hyperplasia. Analysis of 5 studies. Doxazosin Study GroupsEur Urol24319267505224
   PubMed Web of Science ®Google Scholar
• KaplanSAMcConnellJDRoehrbornCG2006Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greaterJ Urol1752172016406915
   PubMed Web of Science ®Google Scholar
• KaplanSASoldoKAOlssonCA1995Terazosin and doxazosin in normotensive men with symptomatic prostatism: a pilot study to determine the effect of dosing regimen on efficacy and safetyEur Urol2822388536776
   PubMed Web of Science ®Google Scholar
• KirbyRSRoehrbornCBoyleP2003Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: The prospective European doxazosin and combination therapy (PREDICT) trialUrology611192612559281
   PubMed Web of Science ®Google Scholar
• KirbyRS2003A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with benign prostatic hyperplasiaBJU Int9414412614248
   PubMed Web of Science ®Google Scholar
• Lee LeeKSChooMSKimDY2005Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicenter studyJ Urol1741334816145414
   PubMed Web of Science ®Google Scholar
• MacDonaldRWiltTJHoweRW2004Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effectsBJU Int9412637015610102
   PubMed Web of Science ®Google Scholar
• McConnellJDRoehrbornCBautistaOM2003The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasiaN Eng J Med349238798
   PubMed Web of Science ®Google Scholar
• MedinaJJParraROMooreRG1999Benign prostatic hyperplasia (the aging prostate)Med Clin North Am8312132910503061
   PubMed Web of Science ®Google Scholar
• RoehrbornCGMcConnellJDBarryMJ2003AUA guideline on the management of benign prostatic hyperplasia [online]Accessed on 28 October 2004. AUA Education and Research, Inc. URL: http://auanet.org/guidelines/bph.cfm
   Google Scholar
• RoehrbornCSiegelRL1996Safety and efficacy of doxazosin in benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studiesUrology48406158804494
   PubMed Web of Science ®Google Scholar
• RollemaHJRosierPJanknegtRA1991Efficacy of alpha-blocker (Doxazosin) in BPH appraised by pressure-flow (CLIM) analysisNeurourol Urodynam1029599
   Google Scholar
• SchultzKFChalmersIHayesRJ1995Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA273408127823387
   PubMed Web of Science ®Google Scholar
• WeiJTCalhounEAJacobsenSJ2004Benign prostatic hyperplasiaLitwinMSSaigalCSUrologic Diseases in America. US Department of Health and Human Services, Public Health Service, National Institute of Health, National Institute of Diabetes and Digestive and Kidney DiseaseWashington, DCUS Government Publishing Office NIH Pubication No. 04-55124370
   Google Scholar